BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16760764)

  • 21. [Diagnosis and management of gastro-esophageal junction tumor].
    Chevallay M; Jung M; Niclauss N; Morel P; Mönig S
    Rev Med Suisse; 2017 Jun; 13(567):1236-1239. PubMed ID: 28643978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staging and restaging of advanced esophageal cancer.
    Jamil LH; Gill KR; Wallace MB
    Curr Opin Gastroenterol; 2008 Jul; 24(4):530-4. PubMed ID: 18622171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.
    Barbour AP; Rizk NP; Gerdes H; Bains MS; Rusch VW; Brennan MF; Coit DG
    J Am Coll Surg; 2007 Oct; 205(4):593-601. PubMed ID: 17903735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodality therapy for esophageal cancer.
    Krasna MJ
    Oncology (Williston Park); 2010 Nov; 24(12):1134-8. PubMed ID: 21141694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer.
    Kalade AV; Eddie Lau WF; Conron M; Wright GM; Desmond PV; Hicks RJ; Chen R
    Intern Med J; 2008 Nov; 38(11):837-44. PubMed ID: 19120534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET.
    Sloof GW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):941-57. PubMed ID: 16997171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response.
    Erasmus JJ; Munden RF
    Semin Radiat Oncol; 2007 Jan; 17(1):29-37. PubMed ID: 17185195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach.
    Lerut T; Moons J; Coosemans W; Decaluwé H; Decker G; De Leyn P; Nafteux P; Van Raemdonck D
    Surg Oncol Clin N Am; 2008 Jul; 17(3):485-502, vii-viii. PubMed ID: 18486879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of gastroesophageal tumors.
    Gee DW; Rattner DW
    Oncologist; 2007 Feb; 12(2):175-85. PubMed ID: 17296813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of locally advanced esophageal cancer with surgery and chemoradiation.
    Siersema PD; van Hillegersberg R
    Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endoscopic ultrasound-guided biopsy: when is it indispensable?].
    Palazzo L
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B79-85. PubMed ID: 12843941
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of fluorodeoxyglucose PET on the management of esophageal cancer.
    Salavati A; Basu S; Heidari P; Alavi A
    Nucl Med Commun; 2009 Feb; 30(2):95-116. PubMed ID: 19194210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Richel DJ; Offerhaus GJ; van Lanschot JJ
    Ann Surg Oncol; 2007 Feb; 14(2):977-91. PubMed ID: 17122988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment for esophageal cancer. Current issues.
    Kato H; Fukuchi M; Miyazaki T; Nakajima M; Tanaka N; Inose T; Kimura H; Faried A; Saito K; Sohda M; Fukai Y; Masuda N; Manda R; Ojima H; Tsukada K; Kuwano H
    Dig Surg; 2007; 24(2):88-95. PubMed ID: 17446703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oesophageal cancer: what's new during the last 10 years?].
    Triboulet JP; Mariette C
    Bull Cancer; 2008 Apr; 95(4):425-31. PubMed ID: 18495572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options.
    Pausawasdi N; Scheiman J
    Curr Opin Gastroenterol; 2007 Sep; 23(5):515-21. PubMed ID: 17762557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staging laparoscopy in gastric cancer. Accuracy and impact on therapy.
    Muntean V; Mihailov A; Iancu C; Toganel R; Fabian O; Domsa I; Muntean MV
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):189-95. PubMed ID: 19565050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
    Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
    J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.